{"organizations": [], "uuid": "e81b0236b5087179708fa93272638d684f96210e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180424.html", "section_title": "Archive News &amp; Video for Tuesday, 24 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-cedilla-therapeutics-a-new-biotech/brief-cedilla-therapeutics-a-new-biotechnology-co-says-launched-april-24-with-56-2-mln-in-series-a-funding-from-third-rock-ventures-idUSFWN1S10NS", "country": "US", "domain_rank": 408, "title": "BRIEF-Cedilla Therapeutics, A New Biotechnology Co, Says Launched April 24 With $56.2 Mln In Series A Funding From Third Rock Ventures", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.348, "site_type": "news", "published": "2018-04-24T19:08:00.000+03:00", "replies_count": 0, "uuid": "e81b0236b5087179708fa93272638d684f96210e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-cedilla-therapeutics-a-new-biotech/brief-cedilla-therapeutics-a-new-biotechnology-co-says-launched-april-24-with-56-2-mln-in-series-a-funding-from-third-rock-ventures-idUSFWN1S10NS", "ord_in_thread": 0, "title": "BRIEF-Cedilla Therapeutics, A New Biotechnology Co, Says Launched April 24 With $56.2 Mln In Series A Funding From Third Rock Ventures", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "neutral"}, {"name": "brief-cedilla therapeutics", "sentiment": "neutral"}, {"name": "new biotechnology co", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " CEDILLA THERAPEUTICS:\n* CEDILLA THERAPEUTICS, A NEW BIOTECHNOLOGY COMPANY, SAYS LAUNCHED APRIL 24 WITH $56.2 MILLION IN SERIES A FUNDING FROM THIRD ROCK VENTURES Source text for Eikon: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-24T19:08:00.000+03:00", "crawled": "2018-04-25T14:18:45.012+03:00", "highlightTitle": ""}